WIRB-Copernicus Group Partners with Veeva Systems Inc.
WCG will create a seamless connection between WCG’s MyConnexus™ IRB document management web portal and Veeva Vault eTMF
PRINCETON, N.J., Nov. 16, 2017 /PRNewswire/ — WIRB-Copernicus Group® (WCG™), the world’s leading provider of solutions that measurably improve the quality and efficiency of clinical research, today announced that it is partnering with Veeva Systems Inc. to improve the speed and accuracy of institutional review board (IRB) document transfer.
“WCG’s goal is to increase the efficiency of the clinical trial process, while maintaining the highest level of human subject protection. Partnering with Veeva will save our clients significant document transfer time and increase the accuracy of the process. This new integration will eliminate any lag time between finalizing an IRB document and uploading it to Veeva Vault eTMF,” said Jill Johnston, president of the WCG Clinical Service Organization.
WCG’s MyConnexus portal serves as a command center, streamlining and enhancing the way sponsors, clinical research organizations (CROs), and investigative sites conduct the IRB submission and document management process. MyConnexus provides unprecedented oversight capabilities and 24/7 access so that clients can manage and track their IRB submissions in real time.
Veeva Vault is a cloud enterprise content and data management platform and suite of applications for life sciences. Veeva Vault eTMF allows active TMF management, providing real-time inspection readiness, enhanced document visibility, and improved control.
“This new partnership with WCG will facilitate the sharing of clinical and regulatory documents between MyConnexus and Vault eTMF, and expedite this element of clinical operations for a large number of sponsors, CROs and sites,” added Jennifer Goldsmith, senior vice president of Veeva Vault.
About WIRB-Copernicus Group
WIRB-Copernicus Group (WCG) is the world’s leading provider of solutions that measurably improve the quality and efficiency of clinical research. The industry’s first clinical services organization (CSO), WCG enables biopharmaceutical companies, CROs, and institutions to accelerate the delivery of new treatments and therapies to patients, while maintaining the highest standards of human subject protections. For more information, please visit www.wcgclinical.com or follow us on Twitter @WCGClinical.